Sihuan Pharmaceutical Holdings Group Company Description
Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People’s Republic of China and the United States.
It operates through three segments: Medical Aesthetic Products, Innovative Medicine and Other Medicine, and Generic Medicine.
The company offers filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care, and others, as well as non- or minimally invasive medical aesthetics comprehensive solutions.
It also provides drugs in the oncology, metabolism, diabetes, cardiovascular and cerebrovascular, modern Chinese medicine, and industrial hemp therapeutic areas.
In addition, the company involved in the provision of research and development, and industrialization of innovative medicine; construction for medical project; provision of general hospital services and hospital management services; and property investment business.
Sihuan Pharmaceutical Holdings Group Ltd. was founded in 2001 and is based in Wan Chai, Hong Kong.
| Country | Bermuda |
| Founded | 2001 |
| Industry | Pharmaceutical Preparations |
| Employees | 2,667 |
| CEO | Weicheng Guo |
Contact Details
Address: Office Tower, Convention Plaza Wan Chai Hong Kong | |
| Phone | 852 3628 3911 |
| Website | sihuanpharm.com |
Stock Details
| Ticker Symbol | TEL1 |
| Exchange | Frankfurt Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Weicheng Guo | Chief Executive Officer |
| Guili Miao | Chief Financial Officer |